NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)
| 1.00 Data as of Jul 25 |  -0.0199 / -1.95%Today’s Change | 0.76 Today|||52-Week Range 2.03 | -18.69% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Assets | Cash | 11.5M | 8.4M | 12.7M | 10.5M | |
| Short Term Investment Cash | 542.0K | -3.1M | 4.3M | -2.2M | ||
| Cash & Short Term Investments | 12.8M | 14.1M | 16.9M | 13.1M | ||
| Receivables | Receivables | 500.0K | 3.0K | 943.0K | 784.0K | |
| Inventories | Inventories | 0.00 | 0.00 | 23.0K | 231.0K | |
| Current Assets | Other Current Assets | 448.0K | 417.0K | 445.0K | 723.0K | |
| Current Assets | 13.8M | 14.6M | 18.3M | 14.8M | ||
| Total Assets | Property, Plant and Equipment - Gross | 3.0M | 3.1M | 2.2M | 2.4M | |
| Depreciation | -1.4M | -1.8M | -1.3M | -1.6M | ||
| Other Assets | 174.0K | 135.0K | 63.0K | 141.0K | ||
| Total Assets | 15.5M | 16.0M | 19.2M | 15.7M | ||
| Liabilities | Accounts Payable | 406.0K | 472.0K | 455.0K | 1.7M | |
| Short Term Debt | 106.0K | 0.00 | 0.00 | 0.00 | ||
| Accrued Expenses | 176.0K | 366.0K | 595.0K | 767.0K | ||
| Other Current Liabilities | 1.7M | 1.7M | 1.8M | 1.1M | ||
| Other Liabilities | 2.7M | 2.8M | 3.2M | 3.6M | ||
| Total Liabilities | Other Liabilities | 0.00 | 2.7M | 1.3M | 1.8M | |
| Total Liabilities | 5.0M | 6.6M | 5.2M | 7.1M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 10.5M | 9.3M | 14.0M | 8.5M | ||
| Total Shareholder Equity | 10.5M | 9.3M | 14.0M | 8.5M | ||
| Share Information | Common Shares Outstanding | 23.4M | 28.6M | 36.9M | 44.6M | |
| Addtl. Info. | No data currently available for this section. | |||||
.
